medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2019, Number 12

<< Back Next >>

Ginecol Obstet Mex 2019; 87 (12)

Troponin I blood concentration in pregnant patients without and with severe preeclampsia

Vázquez-Rodríguez JG

Language: Spanish
References: 16
Page: 807-813
PDF size: 237.69 Kb.


ABSTRACT

Objective: To compare the blood concentration of Troponin I (TI) in pregnant patients without and with severe preeclampsia (SP).
Materials and Methods: Prospective, cross-sectional study, conducted in patients of a medical unit of high specialty of gynecology and obstetrics of Mexico City admitted in the period from January to May of the year 2019. Patients of any age and parity with pregnancy › 20 weeks were selected. Those with previous diseases that may condition myocardial damage were excluded. Venous blood was taken to quantify TI using the “Triage Cardiac Panel”® device of the Biosite® brand that runs an indirect immunofluorescence program coupled to a reader called “Triage Meter”®. For this test the normal value of TI is 0 to 0.4 ng/mL. An electrocardiogram and a chest X-ray were also performed. The results of both groups were compared. Descriptive statistics and the paired Student's T test were used.
Results: 71 women met the selection criteria. Two groups were formed: 37 patients without preeclampsia (group A) and 34 women with PS (group B). The blood concentration of TI in group A was 0.05 ± 0.008 ng / ml and in group B 0.05 ± 0.02 ng/mL (p = 0.30). In group B electrocardiographic abnormalities were found in 14.70% (5 cases) whose TI values were normal. Chest x-ray was normal in 100%.
Conclusions: the blood concentration of TI in pregnant patients without and with PS was normal, including 5 preeclamptic women with electrocardiographic abnormalities.


REFERENCES

  1. García de la Villa B, et al. Valor de la troponina I cardiaca como prueba diagnóstica en el estudio del dolor torácico. Rev Esp Cardiol. 1998; 51: 122-28. https://www.revespcardiol. org/es-pdf-X0300893298002399.

  2. Meráz-Soria CA, et al. Utilidad de la determinación cualitativa de la troponina I y CPK-isoenzima mb en los síndromes coronarios agudos. Arch Cardiol Mex. 2006; 76: 1: 37-46. http://www.scielo.org.mx/scielo.php?script=sci_ arttext&pid=S1405-99402006000100005&lang=pt

  3. Mair J, et al. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponinas I and T for acute myocardial infarction. Clin Chem 1995; 41: 1266-72. http://clinchem. aaccjnls.org/content/clinchem/41/9/1266.full.pdf

  4. Wu AH, et al. Comparison of myoglobin, creatine kinase-MB, and cardiac troponin I for diagnosis of acute myocardial infarction. Ann Clin Lab Sci. 1996; 26: 291-300. https://pdfs.semanticscholar.org/45be/ de 54bb6 a7440246 bf17 ccc4 dab368656 e295. pdf?_ga=2.247304967.2078547910.1567219145- 561243057.1502340689

  5. Georges JL, et al. Time course of troponin I, myoglobin, and cardiac enzyme release after electrical cardioversion. Am J Cardiol. 1996; 1: 825-26. https://doi.org/10.1016/ S0002-9149(96)00430-4.

  6. ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol. 2019;133: e1-e25. doi: 10.1097/AOG.0000000000003018

  7. Barton JR, et al. Endomyocardial ultrastructural findings in preeclampsia. Am J Obstet Gynecol. 1991:165:389-91. doi:https://doi.org/10.1016/0002-9378(91)90100-6

  8. Guía de Práctica Clínica. Actualización 2017. Prevención, Diagnóstico y Tratamiento de la preeclampsia en el segundo y tercer nivel de atención. México. Secretaría de Salud. 2017. http://www.cenetec.salud.gob.mx/contenidos/gpc/ catalogoMaestroGPC.html

  9. Cambronero F. Biomarkers of pathophysiology in hypertrophic cardiomyophaty: implications for clinical management and prognosis. European Heart J 2009; 30: 139-51. doi: 10.1093/eurheartj/ehn538

  10. Fleming SM, et al. Cardiac Troponin I in pre-eclampsia and gestational hypertension. BJOG 2000; 107: 1417-20. https://obgyn.onlinelibrary.wiley.com/doi/ epdf/10.1111/j.1471-0528.2000.tb11658.x

  11. Pasupathi P, et al. Cardiac troponins and oxidative stress markers in non-pregnant, pregnant and preeclampsia women. Bangladesh Med Res Counc Bull. 2010; 36: 4-9. doi:10.3329/bmrcb.v36i1.4806

  12. Beigi A, et al. High Troponin I level among patients with severe preeclampsia. Life Sci J 2013; 10 (11s): 81-83. https://www.researchgate.net/publication/287910165_ High_troponin_I_level_among_patients_with_severe_ preeclampsia

  13. Reyna-Villasmil E, et al. Troponina I en preeclampsia y eclampsia. Progr Obstet Ginecol 2015;58:393-398. https:// reader.elsevier.com/reader/sd/pii/S0304501315001326 ?token=5423E6C9B2C8455CB10C76D571917534400D9 E18C61EB69AC5BEE5E6251BD927E2172DA9C9559906 CFBD91063BE84736

  14. Cot O, et al. Cardiac Troponin I levels in patients with severe preeclampsia and effect of magnesium sulfate treatment on cardiac Troponin I levels. Ş.E.E.A.H. Tıp Bülteni. 2016; 50: 26-32. doi: 10.5350/SEMB.20160107022316

  15. Sprawka N, et al. Troponin I levels in mild and severe preeclampsia. AJOG 2008; Suppl dec: S174. https://www. ajog.org/article/S0002-9378(08)01763-8/pdf

  16. Joyal D, et al. Troponin I levels in patients with preeclampsia. Am J Med. 2007; 120: 819.e13-819.e14. https://www. amjmed.com/article/S0002-9343(06)00897-7/pdf




2020     |     www.medigraphic.com